Promoting Cognitive Health in Schizophrenia
The goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are: * To determine the clinical effectiveness of two virtual cognitive health intervention
| Condition(s) | Schizophrenia, Cognition |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are: * To determine the clinical effectiveness of two virtual cognitive health interventions (i.e., Action-Based Cognitive Remediation or MetaCognitive Training). * To evaluate our implementation strategy involving the virtual delivery of cognitive health interventions combined with a digital learning platform to train mental health practitioners. Participants will be assessed for the severity of symptoms, cognitive performance, and overall functioning before and after receiving the intervention. Qualitative interviews will also be conducted with participants and t |
| Who can participate | Inclusion Criteria: * Diagnosis of affective or non-affective psychosis or related disorder; * Follow-up and treatment by a clinician at one of the services mentioned above; * Participants symptomatically stable and capable of using the online platforms and participating in intervention groups, as judged by their primary clinicians (i.e., psychiatrist, case manager); * Participants must have access to a private space (i.e., a room where the participant can be alone) to ensure confidentiality for the group; * Participants must be able to nominate an emergency contact and to agree to allow researchers to contact their clinician and/or emergency services in the event of an emergency during study procedures. Exclusion Criteria: * Intellectual disability; * Hospitalization at the time of recrui |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Douglas Mental Health University Institute |
| Locations | Vancouver, British Columbia, Canada; Kingston, Ontario, Canada; Ottawa, Ontario, Canada; Toronto, Ontario, Canada; Montreal, Quebec, Canada |
| Start date | 2023-04-15 |
| NCT ID | NCT05661448 |
| Official listing | https://clinicaltrials.gov/study/NCT05661448 |